Tonix Pharmaceuticals Plans Commercial Scale Vaccine Manufacturing Facility

Date Published12/23/2020
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Tonix Pharmaceuticals Holding Corp.
Type of work Manufacturing
If manufacturing, is the company an OEM? Yes
Reshoring category:Reshoring
Year reshoring announced:2020
Year reshoring implemented or to be implemented:2020
Domestically, the work will be done:In-house
City reshored to:Hamilton
State(s) reshored to:MT
If relevant, work nearshored to:-
Industry(ies):Chemicals, bioscience
Product(s) reshoredTNX-1800, COVID-19 vaccine,TNX-801
What domestic positive factors made reshoring more attractive?Eco-system synergies, Impact on domestic economy, Lean/other business process improvement techniques, Other, Covid-19
Find Reshoring Articles